Kadimastem Announces Publication in Frontiers in Endocrinology of a Peer-Reviewed Article
Not compatible with Internet Explorer
Not compatible with Internet Explorer
Not compatible with Internet Explorer



- Apr 26, 2021
- 3 min
Kadimastem Raises NIS 22.3 Million ($6.8 Million)

- Mar 9, 2021
- 3 min
Kadimastem Granted a Patent in Israel for the Treatment of ALS

- Jan 31, 2021
- 5 min
Kadimastem Announces Executive Management Changes


- Dec 15, 2020
- 5 min
Encouraging Results of Cohort B of its Phase 1/2a Clinical Trial of AstroRx® for ALS


- Aug 3, 2020
- 7 min
Kadimastem Reports Positive Interim Results of Cohort B of its AstroRx® Phase 1/2a Clinical Trial in


- Jan 2, 2020
- 7 min
Kadimastem Announces Promising Results of Cohort A of its Phase 1/2a Clinical Trial in ALS


- Dec 23, 2019
- 4 min
Kadimastem Announces the Completion of Treatment for Cohort B


- Nov 19, 2019
- 4 min
Successful Preclinical results of our Cell Therapy Treatment for Insulin-Dependent Diabetes


- Nov 17, 2019
- 4 min
Kadimastem to Submit an Amendment of its ALS Phase 1/2a Clinical Trial Protocol

- Nov 11, 2019
- 3 min
Kadimastem to Present at the 7th International Stem Cell Meeting, in Tel-Aviv


- Sep 24, 2019
- 5 min
Kadimastem Announces Promising Interim Results of Cohort A of its Phase 1/2a Clinical Trial in ALS

- May 20, 2019
- 2 min
Kadimastem Announces Leadership Changes


- Apr 18, 2019
- 2 min
Kadimastem receives Approval from the Ministry of Health of Israel to continue its trial of AstroRX®
- Mar 3, 2019
- 1 min
Appointment of a new CFO for Kadimastem


- Feb 24, 2019
- 2 min
Kadimastem Announces the Completion of Cell Transplantation of AstroRx® in ALS Patients for Cohort A


- Feb 17, 2019
- 1 min
2019 Israel Innovation Authority Budget Approved for Kadimastem: NIS 13.6 M for ALS Project
- Nov 27, 2018
- 1 min
Kadimastem to be included in the TASE Indices
- Nov 14, 2018
- 1 min
Success for Kadimastem: 97% of Warrants (Series 4) Exercised for NIS 3.6M
- Nov 12, 2018
- 2 min
Kadimastem and Defymed Awarded Grant for the Development of a Product for the Treatment of Diabetes